Sensory systems: Normal aging, disorders, and treatments of vision and hearing in humans

Physiological Basis of Aging and Geriatrics, Fourth Edition

Volumn , Issue , 2007, Pages 109-135

  Meisami, Esmail ^a   Brown, Chester M ^a   Emerle, Henry F ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85020138471     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (190)

1. Meisami E. Aging of the sensory systems In: Timiras PS, ed. Physiological Basis of Aging and Geriatrics. 2nd ed. Boca Raton, FL: CRC Press, 1994: 115-131.
2. National Center for Health Statistics Publication, PHS, 1986, pp. 86-1250.
3. Guralnik JM. The impact of vision and hearing impairments on health in old age. J Am Geriatr Soc 1999; 47(8): 1029-1031.
4. Rantanen T, Guralnik JM, Ferrucci L, et al. Coimpairments: strength and balance as predictors of severe walking disability. J Gerontol Med Sci 1999; 54(4): MI72-M176.
5. Ordy JM, Brizee K. In: Ordy JM, Brizee K, eds. Sensory Systems and Communication in the Elderly. New York: Raven Press, 1979.
6. Vaughan WJ, Schmitz P, Fatt I. The human lens: a model system for the study of aging. In: Ordy JM, Brizzee K, eds. Sensory Systems and Communication in the Elderly. New York: Raven Press, 1979: 51-61.
7. Graham P. The eye. In: Pathy MSJ, ed. Principles and Practice of Geriatric Medicine. 2nd ed. 1991: 985-993; see also 3rd ed, 1998, and 4th ed, 2006, edited by Pathy MSJ, et al. London: John Wiley: amberson: Sons.
8. Bron AJ. The aging eye. In: Evans JG andWilliams TF, eds. Oxford Textbook of Geriatric Medicine. Oxford: Oxford University Press, 1992: 557-574; see also 2nd ed, 2000.
9. Leighton DA. Special senses-aging of the eye. In: Brocklehurst JC, ed. Textbook of Geriatric Medicine and Gerontology. Edinbrough: Churchill-Livingstone, 1985: 473-483; see also 5th ed,1998, edited by Tallis R, Fillit H, and Brocklehurst JC.
10. Stefansson E. The eye. In: Hazzard WR et al., eds. Principles of Geriatric Medicine and Gerontology. New York: McGraw-Hill 2nd ed., 1990: 422-431 4th ed, 1999, and 5th ed, 2003.
11. Kuwabara T. Age related changes of the eye. In: Han SS, Coons DH, eds. Special Senses in Aging. Ann Arbor, Institute of Gerontology: University of Michigan, 1979: 46-78.
12. Sekuler R, Kline D, Dismuskes K, eds. Aging and Human Visual Functions. New York: Alan R Liss, 1982.
13. Weale RA. Chap. 3. Focus on Vision. Cambridge, MA: Harvard University Press, 1982.
14. Lass JH, Greiner JV, Merchant TE, et al. The effects of age on phosphatic metabolites of the human cornea. Cornea 1995; 14(1): 89-94.
15. Moller-Pedersen T. A comparative study of human corneal keratocytes and endothelial cell density during aging. Cornea 1997; 16(3): 333-338.
16. Daxer A, Misof K, Grabner B, et al. Collagen fibrils in the human corneal stroma: structure and aging. Invest Ophthalmol Vis Sci 1998; 39(3): 644-648.
17. Oshika T, Oshika T, Klyce SD, et al. Changes in corneal wavefront aberrations with aging. Invest Ophthalmol Vis Sci 1999; 40(7): 1351-1355.
18. Pardhan S, Beesley J. Measurement of corneal curvature in young and older normal subjects. J Refract Surg 1999; 15(4): 469-474.
19. Acosta MC, Alfaro ML, Borras F, et al. Influence of age, gender and iris color on mechanical and chemical sensitivity of the cornea and conjunctiva. Exp Eye Res 2006; 83(4): 932-938.
20. Roszkowska AM, Colosi P, Ferreri FM, et al. Age-related modifications of corneal sensitivity. Ophthalmologica 2004; 218(5): 350-355.
21. Dubbelman M, Sicam VA, Van der Heijde GL. The shape of the anterior and posterior surface of the aging human cornea. Vision Res 2006; 46(6-7): 993-1001.
22. Roszkowska AM, Colosi P, D’Angelo P, et al. Age-related modifications of the corneal endothelium in adults. Int Ophthalmol 2004; 25(3): 163-166.
23. Sanchis-Gimeno JA, Lleo-Perez A, Alonso L, et al. Corneal endothelial cell density decreases with age in emmetropic eyes. Histol Histopathol 2005; 20(2): 423-427.
24. Bron AJ, Vrensen GF, Koretz J, et al. The aging lens. Ophthalmologica 2000; 214(1): 86-104.
25. Koretz JF, Cook CA, Kaufman PL. Aging of the human lens: changes in lens shape at zero-diopter accommodation. J Opt Soc Am A Opt Image Sci Vis 2001; 18(2): 265-272.
26. Dubbelman M, Van der Heijde GL, Weeber HA, et al. Changes in the internal structure of the human crystalline lens with age and accommodation. Vision Res 2003; 43: 2363-2675.
27. Rosen AM, Denham DB, Fernandez V, et al. In vitro dimensions and curvatures of human lenses. Vision Res 2006; 46(6-7): 1002-1009.
28. Marsh G. Perceptual changes with aging. In: Busse EW, Blazer DG, eds. Handbook of Geriatric Psychiatry. New York: Van Nostrand, 1980: 147-168; see also 2nd ed, 1998.
29. Lampi KJ, Lampi KJ, Ma Z, et al. Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res 1998; 67(1): 31-43.
30. Ma Z, Hanson SR, Lampi KJ, et al. Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res 1998; 67(1): 21-30.
31. Wilmarth PA, Tanner S, Dasari S, et al. Age-related changes in human crystallins determined from comparative analysis of posttranslational modifications in young and aged lens: does deamidation contribute to crystallin insolubility? J Proteome Res 2006; 5(10): 2554-2566.
32. Borchman D, Byrdwell WC, Yappert MC. Regional and agedependent differences in the phospholipid composition of human lens membranes. Invest Ophthalmol Vis Sci 1994; 35(11): 3938-3942.
33. Borchman D, Yappert ME. Age-related lipid oxidation in human lenses. Invest Ophthalmol Vis Sci 1998; 39(6): 1053-1058.
34. Ogiso M, Komoto M, Okinaga T, et al. Age-related changes in ganglioside composition in human lens. Exp Eye Res 1995; 60(3): 317-323.
35. Moffat BA, Landman KA, Truscott RJ, et al. Age-related changes in the kinetics of water transport in no Charman WN, and Gray LS. Accommodation responses and aging. Invest Ophthalmol Vis Sci 1999; 40: 2872-2883.
36. Duane A. Accommodation, Arch Ophthalmol 1931; 5: 1-14.
37. Heron G, Charman WN, Gray LS. Accommodation responses and ageing. Invest Ophthalmol Vis Sci 1999; 40(12): 2872-2883.
38. Mordi JA, Ciuffreda KJ. Static aspects of accommodation: age and presbyopia. Vision Res 1998; 38(11): 1643-1653.
39. Glasser A, Campbell MC. Biometric, optical and physical changes in the isolated human crystalline lens with age in relation to presbyopia. Vision Res 1999; 39(11): 1991-2015.
40. Strenk SA, Semmlow JL, Strenk LM, et al. Age-related changes in human ciliary muscle and lens: a Magnetic Resonance Imaging Study. Invest Ophthalmol Vis Sci 1999; 40(6): 1162-1169.
41. Verriest G. Influence of age on usual functions in humans, Bull Acad R Med Belg 1971; 11: 527-578.
42. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M. Retinal photoreceptor density decreases with age. Ophthalmology 1995; 102(12): 1853-1859.
43. Kimble TD, Williams RW. Structure of the cone photoreceptor mosaic in the retinal periphery of adult humans: analysis as a function of age, sex, and hemifield. Anat Embryol (Berl) 2000; 201(4): 305-316.
44. Curcio CA. Photoreceptor topography in aging and age-related maculopathy. Eye 2001; 15(Pt 3): 376-383.
45. Werner JS, Bieber ML, Schefrin BE. Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density. J Opt Soc Am A Opt Image Sci Vis 2000; 17(11): 1918-1932.
46. Cavallotti C, Artico M, Pescosolido N, et al. Age-related changes in the human retina. Can J Ophthalmol 2004; 39(1): 61-68.
47. Garway-Heath DF, Wollstein G, Hitchings RA Aging changes of the optic nerve head in relation to open angle glaucoma. Br J Ophthalmol 1997; 81(10): 840-845.
48. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M. Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes. Am J Ophthalmol 1996; 121(2): 181-189.
49. Boulton M, Dayhaw-Barker P. The role of the retinal pigment epithelium: topographical variation and aging changes. Eye 2001; 15(Pt 3): 384-389.
50. Harman AM, Fleming PA, Hoskins RV, et al. Development and aging of cell topography in the human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1997; 38(10): 2016-2026.
51. Del Priore LV, Kuo YH, Tezel TH. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci 2002; 43(10): 3312-3318.
52. Verdugo ME, Ray J. Age-related increase in activity of specific lysosomal enzymes in the human retinal pigment epithelium. Exp Eye Res 1997; 65(2): 231-240.
53. Cingle KA, Kalski RS, Bruner WE, et al. Age-related changes in glycosides in human retinal pigment epithelium. Curr Eye Res 1996; 15(4): 433-438.
54. Moschner C, Baloh RW. Age-related changes in visual tracking. J Gerontol 1994; 49(5): M235-M238.
55. Munoz DP, Broughton JR, Goldring JE, et al. Age-related performance of human subjects on saccadic eye movement tasks. Exp Brain Res 1998; 121(4): 391-400.
56. McFarland RA, Domey RC, Warren AB, et al. Dark adaptation as as a function of age: I. A statistical analysis. J Gerontol 1960; 15: 149-154.
57. Jackson GR, Owsley C, Cordle EP, et al. Aging and scotopic sensitivity. Vision Res 1998; 38(22): 3655-3662.
58. Schefrin BE, Bieber ML, McLean R, et al. The area of complete scotopic spatial summation enlarges with age. J Opt Soc Am A Opt Image Sci Vis 1998; 15(2): 340-348.
59. McFarland RA, Warren AB, Karis C. Alterations in critical flicker frequency as a function of age and light-dark ratio. J Exp Psychol 1958; 56(6): 529-538.
60. Kim CB, Mayer MJ. Foveal flicker sensitivity in healthy aging eyes. II. Cross-sectional aging trends from 18 through 77 years of age. J Opt Soc Am A 1994; 11(7): 1958-1969.
61. Sekuler R, Sekuler AB. Visual perception and cognition. In: Evans JG, Williams TE, eds. Oxford Textbook of Geriatric Medicine. Oxford: Oxford University Press, 1992: 575-580; see also 2nd ed, 2000 and 3rd ed, 2003.
62. Pitts DG. The effects of aging on selected visual functions: Dark adaptation, visual acuity, stereopsis, and brightness contrast. In: Dismukes K, Sekuler R, Klinesekuler D, eds. Modern Aging Research, vol. 2. Aging and Human Visual Functions. New York: Alan R. Liss, 1982: 101-160.
63. Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision function beyond acuity. Optom Vis Sci 1999; 76(3): 141-158.
64. Sekuler AB, Bennett PJ, Mamelak M. Effects of aging on the useful field of view. Exp Aging Res 2000; 26(2): 103-120.
65. Seiple W, Szlyk JP, Yang S, et al. Age-related functional field losses are not eccentricity dependent. Vision Res 1996; 36(12): 1859-1866.
66. Dolman CL, McCormick AQ, Drance SM. Aging of the optic nerve. Arch Ophthalmol 1980; 98(11): 2053-2058.
67. Brody H, Vijayashankar N. Anatomical changes in the nervous system. In: Finch CE, Hayflick L, eds. Handbook of the Biology of Aging. New York: Van Nostrand, 1977: 241-261.
68. Allison T, Hume AL, Wood CC, et al. Developmental and aging changes in somatosensory, auditory and visual evoked potentials. Electroenceph Clin Neurophysiol 1984; 58(1): 14-24.
69. Justino L, Kergoat H, Kergoat MJ. Changes in the retinocortical evoked potentials in subjects 75 years of age and older. Clin Neurophysiol 2001; 112(7): 1343-1348.
70. Levine BK, Beason-Held LL, Purpura KP, et al. Age-related differences in visual perception: a PET Study. Neurobiol Aging 2000; 21(4): 577-564.
71. Tam WK, Chan H, Brown B, et al. Aging and mfERG topography. Eye 2006; 20(1): 18-24.
72. Hammond CJ, Duncan DD, Snieder H, et al. The heritability of age-related cortical cataract: the Twin Eye Study. Invest Ophthalmol Vis Sci 2001; 42(3): 601-605.
73. Okano Y, Asada M, Fujimoto A, et al. A genetic factor for agerelated cataract: identification and characterization of a novel galactokinase variant, “Osaka,” in Asians. Am J Hum Genet 2001; 68(4): 1036-1042.
74. Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol 2004; 122(4): 487-494.
75. Virgolici B, Popescu L. Risk factors in cataract. Oftalmologia 2006; 50(2): 3-9.
76. Robman L, Taylor H. External factors in the development of cataract. Eye 2005; 19(10): 1074-1082.
77. Broman AT, Hafiz G, Munoz B, et al. Cataract and barriers to cataract surgery in a US Hispanic population: Proyecto VER. Arch Ophthalmol 2005; 123(9): 1231-1236.
78. Congdon N, Broman KW, Lai H, et al. Nuclear cataract shows significant familial aggregation in an older population after adjustment for possible shared environmental factors. Invest Ophthalmol Vis Sci 2004; 45(7): 2182-2186.
79. Yeum KJ, Shang FM, Schalch WM, et al. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr Eye Res 1999; 19(6): 502-505.
80. Sweeney MH, Truscott RJ. An impediment to glutathione diffusion in older normal human lenses: a possible precondition for nuclear cataract. Exp Eye Res 1998; 67(5): 587-595.
81. Zarina S, Zhao HR, Abraham EC. Advanced glycation end products in human senile and diabetic cataractous lenses. Mol Cell Biochem 2000; 210(1-2): 29-34.
82. Gilliland KO, Freel CD, Lane CW, et al. Multilamellar bodies as potential scattering particles in human age-related nuclear cataract. Mol Vis 2001; 7: 120-130.
83. Al-Ghoul KJ, Nordgren RK, Kuszak AJ, et al. Structural evidence of human nuclear fiber compaction as a function of ageing and cataractogenesis. Exp Eye Res 2001; 72(3): 199-214.
84. Dielemans I, Vingerling JR, Algra D, et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995; 102(1): 54-60.
85. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005; 80(5): 709-725.
86. Rachdan D, Lou MF, Harding JJ. Glutathione reductase from human cataract lenses can be revived by reducing agents and by a molecular chaperone, a-crystallin. Curr Eye Res 2005; 30(10): 919-925.
87. Korlimbinis A, Hains PG, Truscott RJ, et al. 3-Hydroxykynurenine oxidizes a-crystallin: potential role in cataractogenesis. Biochemistry 2006; 45(6): 1852-1860.
88. McNeil JJ, Robman L, Tikellis G, et al. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology 2004; 111(1): 75-84.
89. Meyer CH, Sekundo W. Nutritional supplementation to prevent cataract formation. Dev Ophthalmol 2005; 38: 103-119.
90. Funnell CL, Ball J, Noble BA. Comparative cohort study of the outcomes of deep lamellar keratoplasty and penetrating keratoplasty for keratoconus Eye 2006; 20(5): 527-532.
91. Vabres B, Bosnjakowski M, Bekri L, et al. Deep lamellar keratoplasty versus penetrating keratoplasty for keratoconus. J Fr Ophtalmol 2006; 29(4): 361-371.
92. Wirtz MK, Acott TS, Samples JR, et al. Prospects for genetic intervention in primary open-angle glaucoma. Drugs Aging 1998; 13(5): 333-340.
93. La Rosa FA, Lee DA. Collagen degradation in glaucoma: will it gain a therapeutic value? Curr Opin Ophthalmol 2000; 11(2): 90-93.
94. Bergen AA, Leschot NJ, Hulsman CA, et al. From gene to disease; primary open-angle glaucoma and three known genes: MYOC, CYP1B1 and OPTN. Ned Tijdschr Geneeskd 2004; 148(27): 1343-1344.
95. de Voogd S, Ikram MK, Wolfs RC, et al. Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam Study. Ophthalmology 2006; 113(10): 1827-1831.
96. de Voogd S, Wolfs RC, Jansonius NM, et al. Atherosclerosis, Creactive protein, and risk for open-angle glaucoma: the Rotterdam Study. Invest Ophthalmol Vis Sci 2006; 47(9): 3772-3776.
97. Friedman DS, Jampel HD, Munoz B, et al. The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study. Arch Ophthalmol 2006; 124(11): 1625-1630.
98. Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 2004; 111(8): 1439-1448.
99. Tang S, TodaY, Kashiwagi K, et al.The associationbetween Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene. Hum Genet 2003; 113(3): 276-279.
100. Fan BJ, Wang DY, Fan DS, et al. SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients. Mol Vis 2005; 11: 625-631.
101. Sripriya S, Nirmaladevi J, George R, et al. OPTN gene: profile of patients with glaucoma from India. Mol Vis 2006; 12: 816-820.
102. Hoyng PF, Van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs 2000; 59(3): 411-434.
103. Linden C. Therapeutic potential of prostaglandin analogues in glaucoma. Expert Opin Investig Drugs 2001; 10(4): 679-694.
104. Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm 2005; 62(7): 691-699.
105. Marquis RE, Whitson JT. Management of glaucoma: focus on pharmacological therapy. Drugs Aging 2005; 22(1): 1-21.
106. Gierek-Lapinska A, Leszczynski R. Laser therapy in the treatment of glaucoma. Klin Oczna 2004; 106(1-2 suppl): 269-272.
107. Lewis RA. Macular degeneration in the aged. In: Han SS, Coons DH, eds. Special Senses in Aging. Ann Arbor: Institute of Gerontology, University of Michigan, 1979: 93-100.
108. Sarks SH. Aging and degeneration in the macular region. A clinicopathological study. Br J Ophthalmol 1976; 60(5): 324-341.
109. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122(4): 598-614. Review.
110. Kamei M, Hollyfield JG. TIMP-3 in Bruch’s membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci 1999; 40(10): 2367-2375.
111. Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998; 67(6): 637-645.
112. Bailey TA, Alexander RA, Dubovy SR, et al. Measurement of TIMP-3 expression and Bruch’s membrane thickness in human macula. Exp Eye Res 2001; 73(6): 851-858.
113. An E, Lu X, Flippin J, et al. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res 2006; 5(10): 2599-2610.
114. Meyers SM, Greene T, Gutman FA. A twin study of agerelated macular degeneration. Am J Ophthalmol 1995; 120(6): 757-766.
115. Ajani UA, Christen WG, Manson JE, et al. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann Epidemiol 1999; 9(3): 172-177.
116. Chan D. Cigarette smoking and age-related macular degeneration. Optom Vis Sci 1998; 75(7): 476-484.
117. Fekrat S, Bressler SB. Are antioxidants or other supplements protective for age-related macular degeneration? Curr Opin Ophthalmol 1996; 7(3): 65-72.
118. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol 1998; 43(2): 134-146.
119. Rizzo M, Anderson SW, Dawson J, et al. Vision and cognition in Alzheimer’s disease. Neuropsychologia 2000; 38(8): 1157-1169.
120. Rizzo M, Anderson SW, Dawson J, et al. Visual attention impairments in Alzheimer’s disease. Neurology 2000; 54(10): 1954-1959.
121. Hof PR, Vogt BA, Bouras C, et al. Atypical form of Alzheimer’s disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res 1997; 37(24): 3609-3625.
122. Schuknecht HF. Further observations on the pathology of presbycusis. Arch Otolaryngol 1964; 80: 369-382.
123. Gulya AJ. Disorders of hearing. In: Evans JG, Williams TE, eds. Oxford Textbook of Geriatric Medici. Oxford: Oxford University Press, 1992: 580-585; see also 2nd ed, 2000: 893-898.
124. Spoor A. Presbycusis values in relation to noise-reduced hearing loss. Internat Audiol 1967; 6: 48-57.
125. Rosen S, Bergman M, Plester D, et al. Presbycusis study of a relatively noise- free population in the Sudan. Ann Otol Rhinol Laryngol 1962; 71: 727-743.
126. Megighian D, Savastano M, Salvador L, et al. Audiometric and epidemiological analysis of elderly in the Veneto region. Gerontology 2000; 46(4): 199-204.
127. Lee FS, Matthews LJ, Dubno JR, et al. Longitudinal study of pure-tone thresholds in older persons. Ear Hearing 2005; 26(1): 1-11.
128. Spencer JT Jr. Hyperlipoproteinemia and inner ear diseas. Otolaryngol Clin North Am 1975; 8(2): 483-492; see also Spencer JT Jr. Laryngoscope 1973; 83: 639-678.
129. Syka J, Ouda L, Nachtigal P, et al. Atorvastatin slows down the deterioration of inner ear function with age in mice. Neurosci Lett 2007; 411(2): 112-116.
130. Johnsson L, Hawkins JE Jr. Age related degeneration of the inner ear. In: Han SS, Coons DH, eds. Special Senses in Aging. Ann Arbor: Institute of Gerontology, University of Michigan, 1979: 119-136.
131. Someya S, Yamasoba T, Weindruch R, et al. Caloric restriction suppresses apoptotic cell death in the mammalian cochlea and leads to prevention of presbycusis. Neurobiol Aging 2006; [Epub ahead of print].
132. Schuknecht HF. Pathology of the Ear. Cambridge, MA: Harvard University Press, 1974; see also 2nd ed, 1993.
133. Chen MA, Webster P, Yang E, et al. Presbycusic neuritic degeneration within the osseous spiral lamina. Otol Neurotol 2006; 27:(3): 316-322.
134. Kim HN, Kim SG, Lee HK, et al. Incidence of presbycusis of Korean populations in Seoul, Kyunggi and Kangwon provinces. J Korean Med Sci 2000; 15(5): 580-584.
135. Bazargan M, Baker RS, Bazargan SH. Sensory impairments and subjective well-being among aged African-American persons. J Gerontol 2001; 56(5): 268-278.
136. Wiley TL, Cruickshanks KJ, Nondahl DM, et al. Aging and middle ear resonance. J Am Acad Audiol 1999; 10(4): 173-179.
137. Oeken J, Lenk A, Bootz F. Influence of age and presbycusis on DPOAE. Acta Otolaryngol 2000; 120(3): 396-403.
138. Scholtz AW, Kammen-Jolly K, Felder E, et al. Selective aspects of human pathology in high-tone hearing of the aging inner ear. Hear Res 2001; 157(1-2): 77-86.
139. Anniko M, Thornell LE, Wroblewski R. Recent advances in inner ear cytochemistry-microanalytical and immunomorphological investigations. Prog Neurobiol 1988; 30(2-3): 209-269.
140. Felder E, Kanonier G, Scholtz A, et al. Quantitative evaluation of cochlear neurons and computer-aided three-dimensional reconstruction of spiral ganglion cells in humans with a peripheral loss of nerve fibers. Hear Res 1997; 105(1-2): 183-190.
141. Frisina RD, Walton JP. Age-related structural and functional changes in the cochlear nucleus. Hear Res 2006; 216-217: 216-223.
142. Tadros SF, Frisina ST, Mapes F, et al. Higher serum aldosterone correlates with lower hearing thresholds: a possible protective hormone against presbycusis. Hear Res 2005; 209(1-2): 10-18.
143. Popelka MM, Cruickshanks KJ, Wiley TL, et al. Low prevalence of hearing aid use among older adults with hearing loss: the epidemiology of hearing loss study. J Am Geriatr Soc 1998; 46(9): 1075-1078.
144. Jupiter T, Spivey V. Perception of hearing loss and hearing handicap on hearing aid use by nursing home residents. Geriatr Nurs 1997; 18(5): 207-208.
145. Jerger J, Chmiel R, Florin E, et al. Comparison of conventional amplification and an assistive listening device in elderly persons. Ear Hear 1996; 17(6): 490-504.
146. Buchman CA, Fucci MJ, Luxford WM, et al. Cochlear implants in the geriatric population: benefits outweigh risks. Ear Nose Throat J 1998; 78(7): 489-494.
147. Kunimoto M, Yamanaka N, Kimura T, et al. The benefit of cochlear implantation in the Japanese elderly. Auris Nasus Larynx 1999; 26(2): 131-137.
148. Johnson CE, Danhauer JL, Krishnamurti S. A holistic model for matching high-tech hearing aid features to elderly patients. Am J Audiol 2000; 9(2): 112-123.
149. Southall K, Gagne JP, Leroux T. Factors that influence the use of assistance technologies by older adults who have a hearing loss. Int J Audiol 2006; 45(4): 252-259.
150. Feng AS, Jones DL. Localization-based grouping. In: Wang DL, Brown GJ, eds. Computational Auditory Scene Analysis. New York: Wiley Inter-Science, 2006: 187-207.
151. Liu C, Wheeler BC, O’Brien WD Jr, et al. A two-microphone dual delay-line approach for extraction of a speech sound in the presence of multiple interferers. J Acoust Soc Am 2001; 110(6): 3218-3231.
152. Bernstein JM, Shanahan TC, Schaffer FM. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol 1996; 116(5): 666-671.
153. Greene CC, McMillan PM, Barker SE, et al. DFNA25, a novel locus for dominant nonsyndrornic hereditary hearing impairment, maps to 12q21-24. Am J Hum Genet 2001; 68(1): 254-260.
154. Van Laer L, Huizing EH, Verstreken M, et al. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet 1998; 20(2): 194-197.
155. Ueda N, Oshima T, Ikeda K, et al. Mitochondrial DNA deletion is a predisposing cause for sensorineural hearing loss. Laryngoscope 1998; 108(4 pt 1): 580-584.
156. Gates GA, Couropmitree NN, Myers RH. Genetic associations in age-related hearing thresholds. Arch Otolaryngol Head Neck Surg 1999; 125(6): 654-659.
157. Fischel-Ghodsian N, Bykhovskaya Y, Taylor K, et al. Temporal bone analysis of patients with presbycusis reveals high frequency of mitochondrial mutations. Hear Res 1997; 110(1-2): 147-154.
158. Keithley EM, Harris B, Desai K, et al. Mitochondrial cytochrome oxidase immunolabeling in aged human temporal bones. Hear Res 2001; 157(1-2): 93-99.
159. McHugh RK, Friedman RA. Genetics of hearing loss: allelism and modifier genes produce a phenotypic continuum. Anat Rec (A) 2006; 288(4): 370-381.
160. Garringer HJ, Pankratz ND, Nichols WC, et al. Hearing impairment susceptibility in elderly men and the DFNA18 locus. Arch Otolaryngol-Head Neck Surg 2006; 132(5): 506-510.
161. Unal M, Tamer L, Dogruer ZN, et al. N-acetyltransferase 2 gene polymorphism and presbycusis. Laryngoscope 2005; 115(12): 2238-2241.
162. Jerger J, Hayes D. Diagnostic speech audiometry. Arch Otolaryngol 1977; 103(4): 216-222.
163. Bergman M, Bumenfield VG, Cascardo D, et al. Age-related decrement in hearing for speech. Sampling and longitudinal studies. J Gerontol 1976; 31(5): 533-538.
164. Humes LE, Watson BU, Christensen LA, et al. Factors associated with individual differences in clinical measures of speech recognition among the elderly. J Speech Hear Res 1994; 37(2): 465-474.
165. Pichora-Fuller MK, Schneider BA, Daneman M. How young and old adults listen to and remember speech in noise. J Acoust Soc Am 1995; 97(1): 593-608.
166. Frisina DR, Frisina RD. Speech recognition in noise and presbycusis: relations to possible neural mechanisms. Hear Res 1997; 106(1-2): 95-104.
167. Wingfield A, McCoy SL, Peelle JE, et al. Effects of adult aging and hearing loss on comprehension of rapid speech varying in syntactic complexity. J Am Acad Audiol 2006; 17(7): 487-497.
168. Helfer KS. Cross-sectional study of differences in speech understanding between users and nonusers of estrogen replacement therapy. Exp Aging Res 2004; 30(2): 195-204.
169. Kubo T, Sakashita T, Kusuki M, et al. Sound lateralization and speech discrimination in patients with sensorineural hearing loss. Acta Otolaryngol Suppl 1998; 538: 63-69.
170. Schneider BA, Hamstra SJ. Gap detection thresholds as a function of tonal duration for younger and older listeners. J Acoust SocAm 1999; 106(1): 371-380.
171. Feldman ML, Vaughan DW. Changes in the auditory pathway with age. In: Han SS, Coons DH, eds. Special Senses in Aging. Ann Arbor: Institute of Gerontology, University of Michigan, 1979: 143-162.
172. Brody H. Organization of the cerebral cortex III. A study of aging in the human cerebral cortex. J Comp Neurol 1955; 102(2): 511-556.
173. Scheibel ME, Lindsay RD, Tomiyasu U, et al. Progressive dendritic changes in aging human cortex. Exp Neurol 1975; 47(3): 392-402.
174. Turner JG, Hughes LF, Caspary DM. Affects of aging on receptive fields in rat primary auditory cortex layer V neurons. J Neurophysiol 2005; 94(4): 2738-2747.
175. Ruttiger L, Panford-Walsh R, Schimmang T, et al. BDNF mRNA expression and protein localization are changed in agerelated hearing loss. Neurobiol Aging 2007; 28(4): 586-601.
176. Bao J, Lei D, Du Y, et al. Requirement of nicotinic acetylcholine receptor subunit b2 in the maintenance of spiral ganglion neurons during aging. J Neurosci 2005; 25(12): 3041-3045.
177. Le T, Keithley EM. Effects of antioxidants on the aging inner ear. Hear Res 2007; 226(1-2): 194-202.
178. Keithley EM, Canto C, Zheng QY, et al. Cu/Zn superoxide dismutase and age-related hearing loss. Hear Res 2005; 209(1-2): 76-85.
179. Ohlemiller KK. Contributions of mouse models to understanding of age- and noise-related hearing loss. Brain Res 2006; 1091(1): 89-102.
180. Oku T, Hasegewa M. The influence of aging on auditory brainstem response and electrocochleography in the elderly. ORL J Otorhinolaryngol Relat Spec 1997; 59(3): 141-146.
181. Bertoli S, Smurzynski J, Probst R. Effects of age, age-related hearing loss, and contralateral cafeteria noise on the discrimination of small frequency changes: psychoacoustic and electrophysiological measures. J Assoc Res Otolaryngol (JARO) 2005; 6(3): 207-222.
182. Stenklev NC, Laukli E. Cortical cognitive potentials in elderly persons. J Am Acad Audiol 2004; 15(6): 401-413.
183. Pekkonen E, Jaaskelainen IP, Kaakkola S, et al. Cholinergic modulation of preattentive auditory processing in agin. Neuroimage 2005; 27(2): 387-392; see also, Pekkonen E et al. Auditory sensory memory and the cholinergic system: implications for Alzheimer’s disease. Neuroimage 2001; 14: 376-382.
184. Jerger J, Moncrieff D, Greenwald R, et al. Effect of age on interaural asymmetry of event-related potentials in a dichotic listening task. J Am Acad Audiol 2000; 11(7): 383-389.
185. Tremblay KL, Piskosz M, Souza P. Effects of age and age-related hearing loss on the neural representation of speech cues. Clin Neurophysiol 2003; 114(7): 1332-1343.
186. Gordon-Salant S, Lantz J, Fitzgibbons P. Age effects on measures of hearing disability. Ear Hear 1994; 15(3): 262-265.
187. Sinha UK, Saadat D, Linthicum FH Jr, et al. Temporal bone findings in Alzheimer’s disease. Laryngoscope 1996; 106(1 Pt 1): 1-5.
188. Pekkonen E. Mismatch negativity in aging and in Alzheimer’s and Parkinson’s diseases. Audiol Neurootol 2000; 5(3-4): 216-224.
189. Cuddy LL, Duffin J. Music, memory, and Alzheimer’s disease: is music recognition spared in dementia, and how can it be assessed? Med Hypotheses 2005; 64(2): 229-235.
190. Kalayam B, Meyers BS, Kakuma T, et al. Age at onset of geriatric depression and sensorineural hearing deficits. Biol Psychiatry 1995; 38(10): 649-658.